Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review)
- Authors:
- Luca Falzone
- Giuseppe Gattuso
- Saverio Candido
- Alessandro Tomaselli
- Simone Fagone
- Demetrios A. Spandidos
- Massimo Libra
-
Affiliations: Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, I-80131 Naples, Italy, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95123 Catania, Italy, Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95123 Catania, Italy, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece - Published online on: September 19, 2023 https://doi.org/10.3892/ije.2023.19
- Article Number: 5
-
Copyright : © Falzone et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
|
Katsura C, Ogunmwonyi I, Kankam HK and Saha S: Breast cancer: Presentation, investigation and management. Br J Hosp Med (Lond). 83:1–7. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Turashvili G and Brogi E: Tumor heterogeneity in breast cancer. Front Med (Lausanne). 4(227)2017.PubMed/NCBI View Article : Google Scholar | |
|
Sadatmoosavi A, Tajedini O, Esmaeili O, Abolhasani Zadeh F and Khazaneha M: Emerging trends and thematic evolution of breast cancer: Knowledge mapping and co-word analysis. JMIR Cancer. 7(e26691)2021.PubMed/NCBI View Article : Google Scholar | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SL, Chiu SY, Fann JC, et al: Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. 126:2971–2979. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gerami R, Sadeghi Joni S, Akhondi N, Etemadi A, Fosouli M, Eghbal AF and Souri Z: A literature review on the imaging methods for breast cancer. Int J Physiol Pathophysiol Pharmacol. 14:171–176. 2022.PubMed/NCBI | |
|
Cserni G, Francz M, Járay B, Kálmán E, Kovács I, Krenács T, Tóth E, Udvarhelyi N, Vass L, Vörös A, et al: Pathological diagnosis, work-up and reporting of breast cancer 1st Central-Eastern European professional consensus statement on breast cancer. Pathol Oncol Res. 28(1610373)2022.PubMed/NCBI View Article : Google Scholar | |
|
Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO and Ramírez-Valdespino CA: Subtypes of Breast Cancer. In: Breast Cancer. Mayrovitz HN (ed). Exon Publications, Brisbane, AU, 2022. | |
|
Shao J, Rodrigues M, Corter AL and Baxter NN: Multidisciplinary care of breast cancer patients: A scoping review of multidisciplinary styles, processes, and outcomes. Curr Oncol. 26:e385–e397. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Riis M: Modern surgical treatment of breast cancer. Ann Med Surg (Lond). 56:95–107. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Falzone L, Bordonaro R and Libra M: SnapShot: Cancer chemotherapy. Cell. 186:1816–1816.e1. 2023. | |
|
Lau KH, Tan AM and Shi Y: New and emerging targeted therapies for advanced breast cancer. Int J Mol Sci. 23(2288)2022.PubMed/NCBI View Article : Google Scholar | |
|
Liu K, Mao X, Li T, Xu Z and An R: Immunotherapy and immunobiomarker in breast cancer: Current practice and future perspectives. Am J Cancer Res. 12:3532–3547. 2022.PubMed/NCBI | |
|
Zhang X, Yang H and Zhang R: Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions. Biosci Rep. 39(BSR20190230)2019.PubMed/NCBI View Article : Google Scholar | |
|
Vella F, Filetti V, Cirrincione L, Rapisarda V, Matera S, Skerjanc A, Cannizzaro E and Vitale E: Work ability after breast cancer: Study of healthcare personnel operating in a hospital of South Italy. Int J Environ Res Public Health. 19(10835)2022.PubMed/NCBI View Article : Google Scholar | |
|
Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R and Stanisławek A: Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 13(4287)2021.PubMed/NCBI View Article : Google Scholar | |
|
Alkabban FM and Ferguson T: Breast cancer. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, 2023. https://www.ncbi.nlm.nih.gov/books/NBK482286/. Updated September 26, 2022. | |
|
Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES and Cardoso F: Male breast cancer: A disease distinct from female breast cancer. Breast Cancer Res Treat. 173:37–48. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Lavoro A, Scalisi A, Candido S, Zanghì GN, Rizzo R, Gattuso G, Caruso G, Libra M and Falzone L: Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? Int J Oncol. 60(58)2022.PubMed/NCBI View Article : Google Scholar | |
|
Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K and Johansen*Taber K: Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations. Cancer. 126:549–558. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Hao X, Song Z, Zhi X, Zhang S and Zhang J: Correlation between family history and characteristics of breast cancer. Sci Rep. 11(6360)2021.PubMed/NCBI View Article : Google Scholar | |
|
Cohen SY, Stoll CR, Anandarajah A, Doering M and Colditz GA: Modifiable risk factors in women at high risk of breast cancer: A systematic review. Breast Cancer Res. 25(45)2023.PubMed/NCBI View Article : Google Scholar | |
|
Pizot C, Boniol M, Mullie P, Koechlin A, Boniol M, Boyle P and Autier P: Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies. Eur J Cancer. 52:138–154. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Vitale S, Palumbo E, Polesel J, Hebert JR, Shivappa N, Montagnese C, Porciello G, Calabrese I, Luongo A, Prete M, et al: One-year nutrition counselling in the context of a Mediterranean diet reduced the dietary inflammatory index in women with breast cancer: A role for the dietary glycemic index. Food Funct. 14:1560–1572. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Montagnese C, Porciello G, Vitale S, Palumbo E, Crispo A, Grimaldi M, Calabrese I, Pica R, Prete M, Falzone L, et al: Quality of life in women diagnosed with breast cancer after a 12-month treatment of lifestyle modifications. Nutrients. 13(136)2020.PubMed/NCBI View Article : Google Scholar | |
|
Porciello G, Montagnese C, Crispo A, Grimaldi M, Libra M, Vitale S, Palumbo E, Pica R, Calabrese I, Cubisino S, et al: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial. PLoS One. 15(e0239803)2020.PubMed/NCBI View Article : Google Scholar | |
|
Freudenheim JL: Alcohol's effects on breast cancer in women. Alcohol Res. 40(11)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yoo TK, Han KD, Kim D, Ahn J, Park WC and Chae BJ: Hormone replacement therapy, breast cancer risk factors, and breast cancer risk: A nationwide population-based cohort. Cancer Epidemiol Biomarkers Prev. 29:1341–1347. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Seiler A, Chen MA, Brown RL and Fagundes CP: Obesity, dietary factors, nutrition, and breast cancer risk. Curr Breast Cancer Rep. 10:14–27. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Laudisio D, Castellucci B, Barrea L, Pugliese G, Savastano S, Colao A and Muscogiuri G: Mediterranean diet and breast cancer risk: A narrative review. Minerva Endocrinol (Torino). 46:441–452. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ubago-Guisado E, Rodríguez-Barranco M, Ching-López A, Petrova D, Molina-Montes E, Amiano P, Barricarte-Gurrea A, Chirlaque MD, Agudo A and Sánchez MJ: Evidence update on the relationship between diet and the most common cancers from the European prospective investigation into cancer and nutrition (EPIC) study: A systematic review. Nutrients. 13(3582)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kroenke CH, Kwan ML, Sweeney C, Castillo A and Caan BJ: High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 105:616–623. 2013.PubMed/NCBI View Article : Google Scholar | |
|
He Y, Tao Q, Zhou F, Si Y, Fu R, Xu B, Xu J, Li X and Chen B: The relationship between dairy products intake and breast cancer incidence: A meta-analysis of observational studies. BMC Cancer. 21(1109)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wajszczyk B, Charzewska J, Godlewski D, Zemła B, Nowakowska E, Kozaczka M, Chilimoniuk M and Pathak DR: Consumption of dairy products and the risk of developing breast cancer in Polish women. Nutrients. 13(4420)2021.PubMed/NCBI View Article : Google Scholar | |
|
Melnik BC, John SM, Carrera-Bastos P, Cordain L, Leitzmann C, Weiskirchen R and Schmitz G: The role of Cow's milk consumption in breast cancer initiation and progression. Curr Nutr Rep. 12:122–140. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Sirajudeen S, Shah I and Al*Menhali A: A narrative role of vitamin D and its receptor: With current evidence on the gastric tissues. Int J Mol Sci. 20(3832)2019.PubMed/NCBI View Article : Google Scholar | |
|
Benedik E: Sources of vitamin D for humans. Int J Vitam Nutr Res. 92:118–125. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Falzone L: Role of vitamin D in health and disease: How diet may improve vitamin D absorption. Int J Food Sci Nutr. 74:121–123. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Marino R and Misra M: Extra-skeletal effects of vitamin D. Nutrients. 11(1460)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zmijewski MA: Vitamin D and human health. Int J Mol Sci. 20(145)2019.PubMed/NCBI View Article : Google Scholar | |
|
Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling PR, Feldman D, Formenti AM, Lazaretti-Castro M, et al: Consensus statement from 2nd international conference on controversies in vitamin D. Rev Endocr Metab Disord. 21:89–116. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chauhan K, Shahrokhi M and Huecker MR: Vitamin D. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, 2023. https://www.ncbi.nlm.nih.gov/books/NBK441912/. Updated April 9, 2023. | |
|
Malik MZ, Latiwesh OB, Nouh F, Hussain A, Kumar S and Kaler J: Response of parathyroid hormone to vitamin D deficiency in otherwise healthy individuals. Cureus. 12(e9764)2020.PubMed/NCBI View Article : Google Scholar | |
|
Goltzman D, Mannstadt M and Marcocci C: Physiology of the calcium-parathyroid hormone-vitamin D axis. Front Horm Res. 50:1–13. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Naeem Z: Vitamin D deficiency- an ignored epidemic. Int J Health Sci (Qassim). 4:5–6. 2010.PubMed/NCBI | |
|
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P and Jones G: Vitamin D toxicity-A clinical perspective. Front Endocrinol (Lausanne). 9(550)2018.PubMed/NCBI View Article : Google Scholar | |
|
McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, Hollis BW, Trump DL and Lappe JM: Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/l): Pooled analysis of two randomized trials and a prospective cohort. PLoS One. 13(e0199265)2018.PubMed/NCBI View Article : Google Scholar | |
|
Vanhevel J, Verlinden L, Doms S, Wildiers H and Verstuyf A: The role of vitamin D in breast cancer risk and progression. Endocr Relat Cancer. 29:R33–R55. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Jeon SM and Shin EA: Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 50:1–14. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Puspitaningtyas H, Sulistyoningrum DC, Witaningrum R, Widodo I, Hardianti MS, Taroeno-Hariadi KW, Kurnianda J, Purwanto I and Hutajulu SH: Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia. PLoS One. 17(e0270507)2022.PubMed/NCBI View Article : Google Scholar | |
|
de La Puente-Yagüe M, Cuadrado-Cenzual MA, Ciudad-Cabañas MJ, Hernández-Cabria M and Collado-Yurrita L: Vitamin D: And its role in breast cancer. Kaohsiung J Med Sci. 34:423–427. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, et al: Association of serum level of vitamin D at diagnosis with breast cancer survival: A case-cohort analysis in the pathways study. JAMA Oncol. 3:351–357. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Augustin LS, Libra M, Crispo A, Grimaldi M, De Laurentiis M, Rinaldo M, D'Aiuto M, Catalano F, Banna G, Ferrau' F, et al: Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): Design of a clinical trial. BMC Cancer. 17(69)2017.PubMed/NCBI View Article : Google Scholar | |
|
O'Brien J, Hayder H, Zayed Y and Peng C: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 9(402)2018.PubMed/NCBI View Article : Google Scholar | |
|
Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 94:776–780. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Azlan A, Rajasegaran Y, Kang Zi K, Rosli AA, Yik MY, Yusoff NM, Heidenreich O and Moses EJ: Elucidating miRNA function in cancer biology via the molecular genetics' toolbox. Biomedicines. 10(915)2022.PubMed/NCBI View Article : Google Scholar | |
|
Filetti V, La Ferlita A, Di Maria A, Cardile V, Graziano ACE, Rapisarda V, Ledda C, Pulvirenti A and Loreto C: Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure. Sci Rep. 12(9181)2022.PubMed/NCBI View Article : Google Scholar | |
|
Filetti V, Lombardo C, Loreto C, Dounias G, Bracci M, Matera S, Rapisarda L, Rapisarda V, Ledda C and Vitale E: Small RNA-Seq transcriptome profiling of mesothelial and mesothelioma cell lines revealed microrna dysregulation after exposure to asbestos-like fibers. Biomedicines. 11(538)2023.PubMed/NCBI View Article : Google Scholar | |
|
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101:2999–3004. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Jang JH and Lee TJ: The role of microRNAs in cell death pathways. Yeungnam Univ J Med. 38:107–117. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Hao S, Huo S, Du Z, Yang Q, Ren M, Liu S, Liu T and Zhang G: MicroRNA-related transcription factor regulatory networks in human colorectal cancer. Medicine (Baltimore). 98(e15158)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Santolla MF, Lappano R, Cirillo F, Rigiracciolo DC, Sebastiani A, Abonante S, Tassone P, Tagliaferri P, Di Martino MT, Maggiolini M and Vivacqua A: miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. J Exp Clin Cancer Res. 37(94)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lambertini E, Lolli A, Vezzali F, Penolazzi L, Gambari R and Piva R: Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells. BMC Cancer. 12(445)2012.PubMed/NCBI View Article : Google Scholar | |
|
Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, et al: MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst. 102:706–721. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Garofalo M, Quintavalle C, Romano G, Croce CM and Condorelli G: miR221/222 in cancer: Their role in tumor progression and response to therapy. Curr Mol Med. 12:27–33. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Ma L: Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 12(210)2010.PubMed/NCBI View Article : Google Scholar | |
|
Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 283:14910–14914. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Fontana A, Barbano R, Dama E, Pasculli B, Rendina M, Morritti MG, Melocchi V, Castelvetere M, Valori VM, Ravaioli S, et al: Combined analysis of miR-200 family and its significance for breast cancer. Sci Rep. 11(2980)2021.PubMed/NCBI View Article : Google Scholar | |
|
Klicka K, Grzywa TM, Mielniczuk A, Klinke A and Włodarski PK: The role of miR-200 family in the regulation of hallmarks of cancer. Front Oncol. 12(965231)2022.PubMed/NCBI View Article : Google Scholar | |
|
Hossain MM, Sultana A, Barua D, Islam MN, Gupta A and Gupta S: Differential expression, function and prognostic value of miR-17-92 cluster in ER-positive and triple-negative breast cancer. Cancer Treat Res Commun. 25(100224)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, et al: Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132:875–186. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Imani S, Wu RC and Fu J: MicroRNA-34 family in breast cancer: From research to therapeutic potential. J Cancer. 9:3765–3775. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Tang W, Li GS, Li JD, Pan WY, Shi Q, Xiong DD, Mo CH, Zeng JJ, Chen G, Feng ZB, et al: The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study. Pathol Res Pract. 216(152754)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu X, Papukashvili D, Wang Z, Liu Y, Chen X, Li J, Li Z, Hu L, Li Z, Rcheulishvili N, et al: Potential utility of miRNAs for liquid biopsy in breast cancer. Front Oncol. 12(940314)2022.PubMed/NCBI View Article : Google Scholar | |
|
Gattuso G, Crimi S, Lavoro A, Rizzo R, Musumarra G, Gallo S, Facciponte F, Paratore S, Russo A, Bordonaro R, et al: Liquid biopsy and circulating biomarkers for the diagnosis of precancerous and cancerous oral lesions. Noncoding RNA. 8(60)2022.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Tang D, Zheng S, Su R and Tang Y: Serum microRNA-195 as a potential diagnostic biomarker for breast cancer: A systematic review and meta-analysis. Int J Clin Exp Pathol. 12:3982–3991. 2019.PubMed/NCBI | |
|
Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K and Schwarzenbach H: Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem. 59:1489–1496. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Fortis SP, Vaxevanis CK, Mahaira LG, Sofopoulos M, Sotiriadou NN, Dinou A, Arnogiannaki N, Stavropoulos-Giokas C, Thanos D, Baxevanis CN and Perez SA: Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics. Cancer Immunol Immunother. 68:57–70. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Cardinali B, Tasso R, Piccioli P, Ciferri MC, Quarto R and Del*Mastro L: Circulating miRNAs in breast cancer diagnosis and prognosis. Cancers (Basel). 14(2317)2022.PubMed/NCBI View Article : Google Scholar | |
|
Gambari R, Brognara E, Spandidos DA and Fabbri E: Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol. 49:5–32. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Falzone L, Grimaldi M, Celentano E, Augustin LSA and Libra M: Identification of modulated MicroRNAs associated with breast cancer, diet, and physical activity. Cancers (Basel). 12(2555)2020.PubMed/NCBI View Article : Google Scholar | |
|
Olson J, Sheean P, Matthews L, Chitambar CR, Banerjee A, Visotcky A, Bonini M and Stolley M: Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer. Future Sci OA. 7(FSO694)2021.PubMed/NCBI View Article : Google Scholar | |
|
Humphries B, Wang Z and Yang C: MicroRNA regulation of epigenetic modifiers in breast cancer. Cancers (Basel). 11(897)2019.PubMed/NCBI View Article : Google Scholar | |
|
Momi N, Kaur S, Rachagani S, Ganti AK and Batra SK: Smoking and microRNA dysregulation: A cancerous combination. Trends Mol Med. 20:36–47. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Giambò F, Leone GM, Gattuso G, Rizzo R, Cosentino A, Cinà D, Teodoro M, Costa C, Tsatsakis A, Fenga C and Falzone L: Genetic and epigenetic alterations induced by pesticide exposure: Integrated analysis of gene expression, microRNA expression, and DNA methylation datasets. Int J Environ Res Public Health. 18(8697)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gattuso G, Falzone L, Costa C, Giambò F, Teodoro M, Vivarelli S, Libra M and Fenga C: Chronic pesticide exposure in farm workers is associated with the epigenetic modulation of hsa-miR-199a-5p. Int J Environ Res Public Health. 19(7018)2022.PubMed/NCBI View Article : Google Scholar | |
|
Krauskopf J, de Kok TM, Hebels DG, Bergdahl IA, Johansson A, Spaeth F, Kiviranta H, Rantakokko P, Kyrtopoulos SA and Kleinjans JC: MicroRNA profile for health risk assessment: Environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery. Sci Rep. 7(9262)2017.PubMed/NCBI View Article : Google Scholar | |
|
Bailey KA and Fry RC: Arsenic-associated changes to the epigenome: What are the functional consequences? Curr Environ Health Rep. 1:22–34. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kasiappan R and Rajarajan D: Role of MicroRNA regulation in obesity-associated breast cancer: Nutritional perspectives. Adv Nutr. 8:868–888. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kwon YJ, Cho YE, Cho AR, Choi WJ, Yun S, Park H, Kim HS, Cashion AK, Gill J, Lee H and Lee JW: The possible influence of mediterranean diet on extracellular vesicle miRNA expression in breast cancer survivors. Cancers (Basel). 12(1355)2020.PubMed/NCBI View Article : Google Scholar | |
|
Blasiak J, Chojnacki J, Pawlowska E, Jablkowska A and Chojnacki C: Vitamin D may protect against breast cancer through the regulation of long noncoding RNAs by VDR signaling. Int J Mol Sci. 23(3189)2022.PubMed/NCBI View Article : Google Scholar | |
|
Socha M and Sobiech KA: Eating habits, risk of breast cancer, and diet-dependent quality of life in postmenopausal women after mastectomy. J Clin Med. 11(4287)2022.PubMed/NCBI View Article : Google Scholar | |
|
Adinew GM, Taka E, Mendonca P, Messeha SS and Soliman KFA: The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer. Nutrients. 13(1212)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zabaleta ME, Forbes-Hernández TY, Simal-Gandara J, Quiles JL, Cianciosi D, Bullon B, Giampieri F and Battino M: Effect of polyphenols on HER2-positive breast cancer and related miRNAs: Epigenomic regulation. Food Res Int. 137(109623)2020.PubMed/NCBI View Article : Google Scholar | |
|
Otsuka K, Yamamoto Y and Ochiya T: Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer. Oncotarget. 9:24718–24730. 2018.PubMed/NCBI View Article : Google Scholar | |
|
LeMay-Nedjelski L, Mason-Ennis JK, Taibi A, Comelli EM and Thompson LU: Omega-3 polyunsaturated fatty acids time-dependently reduce cell viability and oncogenic MicroRNA-21 expression in estrogen receptor-positive breast cancer cells (MCF-7). Int J Mol Sci. 19(244)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cui J, Zhou B, Ross SA and Zempleni J: Nutrition, microRNAs, and Human Health. Adv Nutr. 8:105–112. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Quintanilha BJ, Reis BZ, Duarte GBS, Cozzolino SMF and Rogero MM: Nutrimiromics: Role of microRNAs and nutrition in modulating inflammation and chronic diseases. Nutrients. 9(1168)2017.PubMed/NCBI View Article : Google Scholar | |
|
Milenkovic D, Jude B and Morand C: miRNA as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med. 64:40–51. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Yu B, He J and Chen D: From nutrient to MicroRNA: a novel insight into cell signaling involved in skeletal muscle development and disease. Int J Biol Sci. 12:1247–1261. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Shaikh AA, Braakhuis AJ and Bishop KS: The mediterranean diet and breast cancer: A personalised approach. Healthcare (Basel). 7(104)2019.PubMed/NCBI View Article : Google Scholar | |
|
Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB and Holick MF: The role of vitamin D in cancer prevention. Am J Public Health. 96:252–261. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 128:1414–1424. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hu K, Callen DF, Li J and Zheng H: Circulating vitamin D and overall survival in breast cancer patients: A dose-response meta-analysis of cohort studies. Integr Cancer Ther. 17:217–225. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ling Y, Xu F, Xia X, Dai D, Sun R and Xie Z: Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex. J Mol Endocrinol. 68:137–151. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Ferrero G, Carpi S, Polini B, Pardini B, Nieri P, Impeduglia A, Grioni S, Tarallo S and Naccarati A: Intake of natural compounds and circulating microRNA expression levels: Their relationship investigated in healthy subjects with different dietary habits. Front Pharmacol. 11(619200)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kura B, Parikh M, Slezak J and Pierce GN: The influence of diet on MicroRNAs that impact cardiovascular disease. Molecules. 24(1509)2019.PubMed/NCBI View Article : Google Scholar | |
|
Uberti F, Morsanuto V, Aprile S, Ghirlanda S, Stoppa I, Cochis A, Grosa G, Rimondini L and Molinari C: Biological effects of combined resveratrol and vitamin D3 on ovarian tissue. J Ovarian Res. 10(61)2017.PubMed/NCBI View Article : Google Scholar | |
|
Biersack B: Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention. Noncoding RNA Res. 1:12–34. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kocic H, Damiani G, Stamenkovic B, Tirant M, Jovic A, Tiodorovic D and Peris K: Dietary compounds as potential modulators of microRNA expression in psoriasis. Ther Adv Chronic Dis. 10(2040622319864805)2019.PubMed/NCBI View Article : Google Scholar | |
|
Gleba JJ, Kłopotowska D, Banach J, Mielko KA, Turlej E, Maciejewska M, Kutner A and Wietrzyk J: Micro-RNAs in response to active forms of vitamin D3 in human leukemia and lymphoma cells. Int J Mol Sci. 23(5019)2022.PubMed/NCBI View Article : Google Scholar | |
|
Mohri T, Nakajima M, Takagi S, Komagata S and Yokoi T: MicroRNA regulates human vitamin D receptor. Int J Cancer. 125:1328–1333. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wahler J, So JY, Kim YC, Liu F, Maehr H, Uskokovic M and Suh N: Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog. Cancer Prev Res (Phila). 7:617–626. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wahler J, Cheng LC, Maehr H, Uskokovic M and Suh N: Abstract 1912: Reduction of microRNA-21 by vitamin D compounds during ductal carcinoma in situ transition to invasive ductal carcinoma. Cancer Res. 75 (15 Suppl)(S1912)2015. | |
|
Singh T and Adams BD: The regulatory role of miRNAs on VDR in breast cancer. Transcription. 8:232–241. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Essa S, Reichrath S, Mahlknecht U, Montenarh M, Vogt T and Reichrath J: Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res. 32:383–389. 2012.PubMed/NCBI | |
|
Liu X, Bi L, Wang Q, Wen M, Li C, Ren Y, Jiao Q, Mao JH, Wang C, Wei G and Wang Y: miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer. Oncogene. 37:3426–3439. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 27:3757–3763. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KEO and Mehta RG: Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem. 110:1324–1333. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Huang FY, Wong DKH, Seto WK, Lai CL and Yuen MF: Estradiol induces apoptosis via activation of miRNA-23a and p53: Implication for gender difference in liver cancer development. Oncotarget. 6:34941–34952. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang F, Wang B, Long H, Yu J, Li F, Hou H and Yang Q: Decreased miR-124-3p expression prompted breast cancer cell progression mainly by targeting beclin-1. Clin Lab. 62:1139–1145. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Li Y, Cook KL, Yu W, Jin L, Bouker KB, Clarke R and Hilakivi-Clarke L: Inhibition of antiestrogen-promoted pro-survival autophagy and tamoxifen resistance in breast cancer through vitamin D receptor. Nutrients. 13(1715)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Wei Y, Fan X, Zhang P, Wang P, Cheng S and Zhang J: MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer. Thorac Cancer. 11:1613–1620. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 282:1479–1486. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Shahrzad MK, Gharehgozlou R, Fadaei S, Hajian P and Mirzaei HR: Vitamin D and non-coding RNAs: New insights into the regulation of breast cancer. Curr Mol Med. 21:194–210. 2021.PubMed/NCBI View Article : Google Scholar |
